The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...

The government is working to head off human bird flu infections. The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 ...

Can't find eggs at your local grocery store? You're not alone. The recent H5N1 bird flu has led to the culling of millions of ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

Going out to breakfast with the family? Well, if you plan on going to Waffle House, you’re going to have to pay a little ...